ARTICLE | Company News
Stallergenes, Ares Life Sciences, Wendel inflammation news
November 22, 2010 8:00 AM UTC
Fellow investment firm Ares completed its previously announced acquisition of Wendel's 45.86% interest in Stallergenes for €358.8 million ($489.2 million), or €59 per share. Ares said it will file a m...